SAB’s therapeutic shows promising results against Delta, other variants
The treatment developed by Sioux Falls-based SAB Biotherapeutics for the virus that causes COVID-19 has shown “effective and potent” ability to neutralize multiple variants of concern, including the Delta and Lambda variants.